IRIS
SOLIMANDO, ANTONIO GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.297
AS - Asia 4.430
EU - Europa 4.137
SA - Sud America 1.142
AF - Africa 268
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 18.287
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.059
SG - Singapore 1.858
IT - Italia 1.756
BR - Brasile 898
CN - Cina 824
HK - Hong Kong 507
RU - Federazione Russa 447
SE - Svezia 414
DE - Germania 409
VN - Vietnam 359
FR - Francia 344
GB - Regno Unito 224
BD - Bangladesh 195
IN - India 161
FI - Finlandia 153
CA - Canada 126
ID - Indonesia 94
AR - Argentina 71
CI - Costa d'Avorio 67
ZA - Sudafrica 60
MX - Messico 59
IQ - Iraq 57
PL - Polonia 56
TR - Turchia 56
JP - Giappone 51
NL - Olanda 51
ES - Italia 49
CO - Colombia 47
PK - Pakistan 38
BE - Belgio 37
CZ - Repubblica Ceca 36
AT - Austria 31
VE - Venezuela 30
UA - Ucraina 28
EC - Ecuador 27
EG - Egitto 26
LT - Lituania 26
MA - Marocco 26
PH - Filippine 26
SA - Arabia Saudita 26
KR - Corea 24
UZ - Uzbekistan 23
JO - Giordania 22
TN - Tunisia 22
CL - Cile 20
MY - Malesia 20
KE - Kenya 17
PY - Paraguay 17
IE - Irlanda 16
AE - Emirati Arabi Uniti 15
ET - Etiopia 14
AU - Australia 10
DZ - Algeria 10
NP - Nepal 10
PE - Perù 10
BO - Bolivia 9
IR - Iran 9
JM - Giamaica 9
CH - Svizzera 8
UY - Uruguay 8
CR - Costa Rica 7
PA - Panama 7
KW - Kuwait 6
LB - Libano 6
AO - Angola 5
HU - Ungheria 5
NI - Nicaragua 5
OM - Oman 5
PS - Palestinian Territory 5
RO - Romania 5
AZ - Azerbaigian 4
DK - Danimarca 4
HR - Croazia 4
IL - Israele 4
NO - Norvegia 4
RS - Serbia 4
SR - Suriname 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
AL - Albania 3
BG - Bulgaria 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
PT - Portogallo 3
QA - Qatar 3
SN - Senegal 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BF - Burkina Faso 2
EE - Estonia 2
GD - Grenada 2
GE - Georgia 2
GM - Gambi 2
GR - Grecia 2
HT - Haiti 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
Totale 18.245
Salva come PNG Salva come JPEG
Città #
Ashburn 1.148
Singapore 1.096
San Jose 631
Chandler 605
Fairfield 570
Hong Kong 501
Milan 472
Nyköping 341
Woodbridge 305
Beijing 273
New York 259
Houston 256
Seattle 254
Cambridge 235
Los Angeles 214
Bari 206
Ann Arbor 201
Rome 183
Wilmington 176
Council Bluffs 174
Lauterbourg 147
Dallas 146
Munich 114
Ho Chi Minh City 110
Helsinki 109
Dearborn 100
Roxbury 93
Lawrence 92
Boardman 88
Columbus 84
Falkenstein 84
Marseille 84
Santa Clara 84
São Paulo 83
Des Moines 71
Buffalo 68
Abidjan 67
Brooklyn 67
Hanoi 67
Jakarta 67
Chicago 63
Frankfurt am Main 62
Moscow 60
Orem 48
London 46
Tokyo 46
San Diego 45
Figino 44
Nanjing 44
Montreal 42
Inglewood 40
Johannesburg 40
Dong Ket 39
Brussels 37
Denver 37
Toronto 37
Turku 36
Atlanta 32
Turin 32
Warsaw 32
Paris 31
Phoenix 29
Stockholm 29
Chennai 27
Brno 26
Jacksonville 25
Manchester 24
Poplar 24
The Dalles 24
Naples 23
Nuremberg 23
Redwood City 23
Baghdad 22
Boston 21
Rio de Janeiro 21
Tashkent 21
Amman 20
San Francisco 20
Washington 20
Guangzhou 19
Mexico City 19
Princeton 19
Campinas 18
Salt Lake City 17
Shanghai 17
Curitiba 16
Dublin 16
Florence 16
Haiphong 16
Leawood 16
Tampa 16
Dhaka 15
Amsterdam 14
Augusta 14
Belo Horizonte 14
Brescia 14
Elk Grove Village 14
Mumbai 14
Pune 14
Salvador 14
Totale 11.572
Salva come PNG Salva come JPEG
Nome #
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival 298
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores the angiogenic homeostasis and suppresses tumor progression 246
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease. 223
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 223
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 216
B-Cell Therapies in Relapsing Remitting and Primary Progressive Multiple Sclerosis: A Short Clinical Review 202
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer 192
Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma 191
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 190
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 189
The small subunit of Hemilipin2, a new heterodimeric phospholipase A2 from Hemiscorpius lepturus scorpion venom, mediates the antiangiogenic effect of the whole protein 188
Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study 188
Microenvironment drug resistance in multiple myeloma: Emerging new players 186
JAM-A as a Prognostic Factor and New Therapeutic Target in Multiple Myeloma 185
HB-EGF–EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma 184
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 179
Targeting B-cell non Hodgkin lymphoma: New and old tricks 175
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 173
Bone metastasis as primary presentation of pancreatic ductal adenocarcinoma: A case report and literature review 173
A multiple myeloma that progressed as type i cryoglobulinemia with skin ulcers and foot necrosis: A case report 169
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 164
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 162
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma 161
BL1391: an established cell line from a human malignant peripheral nerve sheath tumor with unique genomic features 158
Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass 157
Efficacy and safety of benralizumab in eosinophilic granulomatosis with polyangiitis: A meta‐analysis of eight studies 155
Bortezomib treatment modulates autophagy in multiple myeloma 154
A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target 154
A comprehensive biological and clinical perspective can drive a patient-tailored approach to multiple myeloma: Bridging the gaps between the plasma cell and the neoplastic niche 152
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer 151
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 149
Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment 149
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs 149
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside 146
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 145
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 143
Imaging evaluation of pulmonary and non-ischaemic cardiovascular manifestations of covid-19 143
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma 142
Dyspnea, Fatigue, and Generalized Weakness in a 67-Year-Old Man: Approach to the Patient Between Guidelines and Clinical Judgment 139
Amyloid heart involvement lead a fast fatal evolution a healthy woman: a case report 139
Emerging Concepts in Acute Heart Failure: From the Pathophysiology to the Clinical Case Based Approach 139
Cytotoxic t-lymphocyte antigen-4 in colorectal cancer: Another therapeutic side of capecitabine 137
Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib 136
Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review 135
A Challenging Case of Visceral Leishmaniasis 134
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF‐MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement 133
Actors on the scene: Immune cells in the myeloma niche 133
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection 133
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery 132
Angiogenesis and Antiangiogenesis in Multiple Myeloma 132
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 131
CORRELATION BETWEEN VASCULAR INFLAMMATION MARKERS, DIASTOLIC DYSFUNCTION AND CARDIOVASCULAR RISK IN PATIENTS WITH TAKAYASU ARTERITIS 131
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice 131
RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS 129
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? 129
CIC-Mutation As a Potential Molecular Mechanism of Acquired Resistance to Combined BRAF/MEK Inhibition in CNS Multiple Myeloma 129
A t(4;13)(q21;q14) translocation in B-cell chronic lymphocytic leukemia causing concomitant homozygous DLEU2/miR15a/miR16-1 and heterozygous ARHGAP24 deletions 126
Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs 126
Case Report: Lymphocytosis Associated With Fatal Hepatitis in a Thymoma Patient Treated With Anti-PD1: New Insight Into the Immune-Related Storm 125
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 119
Proangiogenic effect of bone marrow fibroblasts in patients with multiple myeloma 119
Exploration of Artificial Intelligence Use with ARIES in Multiple Myeloma Research 118
Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion 117
Antibiotic treatment in vasculitic leg ulcers: a single center experience 117
Fever, cough and breathlessness in a patient with digeorge syndrome 117
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease 116
A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study 115
Sonography of superficial lymph nodes in malignant lymphomas. Data from our case series. 111
Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study 111
Two-year follow-up after drug desensitization in mucopolysaccharidosis 110
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study 108
Real-life experience with omalizumab in chronic spontaneous urticaria. 107
Prognostic role of neoplastic markers in Takotsubo syndrome 106
Genomic profiling at a single center cracks the code in inborn errors of immunity 105
Aplastic Anemia as a Roadmap for Bone Marrow Failure: An Overview and a Clinical Workflow 105
Telemedicine DSS-AI Multi Level Platform for Monoclonal Gammopathy Assistance 105
Breaking through Multiple Myeloma: A Paradigm for a Comprehensive Tumor Ecosystem Targeting 104
The bone marrow niche landscape: a journey through aging, extrinsic and intrinsic stressors in the haemopoietic milieu 102
Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes 101
LIPIDS INCREASE IN HYPERTENSIVES DURING THE FIRST YEAR STEROID TREATMENT FOR GRANULOMATOSIS WITH POLYANGIITIS (GPA) 101
Rituximab induces a reduction of lymphocyte CD3+ activated in patients with autoimmune diseases 101
Induction therapy and stem cell mobilization in patients with newly diagnosed multiple myeloma 101
CARDIOVASCULAR RISK SCORE MAY BE USEFUL IN STRATIFY DEATH RISK IN HOSPITALIZED COVID19 PATIENTS 100
A Markov model for estimating the cost-effectiveness of immunotherapy for newly diagnosed multiple myeloma patients 100
Identification and monitoring of Copy Number Variants (CNV) in monoclonal gammopathy 99
Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review 98
An atypical presentation of intestinal neuroendocrine tumor. 98
Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma: Could Surgery Represent a Therapeutic Option? 96
Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions 96
Aggressive systemic mastocytosis with the co-occurrence of PRKG2::PDGFRB, KAT6A::NCOA2, and RXRA::NOTCH1 fusion transcripts and a heterozygous RUNX1 frameshift mutation 95
Immune system and bone microenvironment: rationale for targeted cancer therapies 95
Changes in Angiogenesis and Bone Turnover Markers in Patients with Gaucher Disease Developing Osteonecrosis 95
Difference in growth hormone response to growth hormone-releasing hormone (GHRH) testing following GHRH subacute treatment in normal aging and growth hormone-deficient adults: Possible perspectives for therapeutic use of GHRH or its analogs in elderly subjects? 94
New insights in Diffuse Large B Cell Lymphoma Pathobiology 94
Rituximab use in autoimmune diseases: a single center experience. 93
Angiogenesis as Therapeutic Target in Metastatic Prostate Cancer – Narrowing the Gap Between Bench and Bedside 93
Comprehensive analysis of clinical outcomes, infectious complications and microbiological data in newly diagnosed multiple myeloma patients: a retrospective observational study of 92 subjects 92
STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failure 92
MicroRNAs-based nano-strategies as new therapeutic approach in multiple myeloma to overcome disease progression and drug resistance 92
Acyclovir desensitization. A case report and a review of desensitization strategies 92
Totale 13.713
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.291
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.291
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022941 79 36 30 33 40 84 38 50 76 82 135 258
2022/20231.550 155 220 128 123 145 170 43 186 280 26 50 24
2023/2024866 48 121 54 76 75 258 32 21 20 24 16 121
2024/20253.613 150 57 172 130 134 313 538 355 160 220 522 862
2025/20268.795 1.066 374 498 903 1.019 483 904 312 1.033 813 448 942
2026/2027356 356 0 0 0 0 0 0 0 0 0 0 0
Totale 19.250